Idiopathic pulmonary fibrosis trials in Italy

In Italy 22 Also abroad 111

22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Where
Foggia, Forli', Modena, Monza, Pavia, Rozzano, Siena, Turin
Age
18 years and over
People
139 worldwide
Run by
AstraZeneca AB
See details and how to join2025-525016-41-00 · EU 2025-525016-41-00
Phase 2Taking people
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Where
Catania, Florence, Modena, Naples, Rome, Siena
Age
40 years and over
People
324 worldwide
Run by
Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00
Phase 2Taking people
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Where
Milan, Pavia
Age
18 years and over
People
340 worldwide
Run by
Avalyn Pharma Inc.
See details and how to joinNCT06951217
Phase 2Not yet taking people in Italy
A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
Where
Alexandria, Bergamo, Bologna, Foggia, Forli', Modena, Monza, Palermo, Pavia, Rome, Siena
Age
18 years and over
People
112 worldwide
Run by
Agomab Spain S.L.U.
See details and how to join2026-526404-71-00 · EU 2026-526404-71-00
Phase 3Not yet taking people in Italy
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
Where
Bergamo, Bologna, Florence, Foggia, Milan, Modena, Naples, Palermo, Pavia, Rome, Sassari, Siena
Age
18 years and over
People
2,380 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00
Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Where
Foggia, Forlì, Modena, Monza, Pavia, Rozzano, Siena, Torino
Age
40 years and over
People
359 worldwide
Run by
AstraZeneca
See details and how to joinNCT07652658
Phase 3Taking people
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Where
Bologna, Catania, Forli', Modena, Rimini, Siena
Age
40 years and over
People
1,100 worldwide
Run by
PureTech
See details and how to joinNCT07284602 · EU 2025-524493-42-00
Phase 3Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Where
Ancona, Catania, Forlì, Milan, Modena, Roma, Rome, Siena
Age
40 years and over
People
1,850 worldwide
Run by
United Therapeutics
See details and how to joinNCT04905693
Phase 2Taking people
A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Where
Ferrara, Foggia, Milan, Modena, Monza, Padova, Rome, Siena, Verona
Age
40 years and over
People
240 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07516951 · EU 2024-514246-37-00
Phase 2Taking people
An Open-Label Extension Study of Subjects who Received an Avalyn Inhaled Antifibrotic Agent
Where
Bologna, Milan, Naples, Pavia, Rozzano
Age
18 years and over
People
128 worldwide
Run by
Avalyn Pharma Inc.
See details and how to join2024-518289-28-00 · EU 2024-518289-28-00
Phase 2Taking people
AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
Where
Ancona, Bologna, Catania, Florence, Forli', Milan, Modena, Pavia, Rimini, Rome, Siena
Age
40 years and over
People
160 worldwide
Run by
Avalyn Pharma Inc.
See details and how to joinNCT07194382 · EU 2025-523431-19-00
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
Where
Ancona, Bergamo, Bologna, Florence, Foggia, Forli', Milan, Modena, Monza, Napoli, Palermo, Pavia, Pisa, Rome, Sassari, Siena
Age
18 years and over
People
239 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503697-21-01 · EU 2023-503697-21-01
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
Where
Ancona, Bergamo, Florence, Foggia, Forli', Milan, Modena, Monza, Napoli, Palermo, Pavia, Pisa, Rome, Sassari, Siena
Age
18 years and over
People
249 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503699-25-00 · EU 2023-503699-25-00
Phase 2Taking people
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Where
Catania, Florence, Modena, Rome, Verona
Age
40 years and over
People
165 worldwide
Run by
AbbVie
See details and how to joinNCT07230288 · EU 2024-518013-25-00
No phaseTaking people
Photon-counting CT Scan vs Standard HRCT Scan in the Identification of Idiopathic Pulmonary Fibrosis
Where
Rozzano
Age
18 years and over
People
156
Run by
Istituto Clinico Humanitas
See details and how to joinNCT07790614
No phaseTaking people
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Where
Rimini
Age
18 years to 80 years
People
500 worldwide
Run by
University of Massachusetts, Worcester
See details and how to joinNCT06855329
No phaseTaking people
Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia
Where
Milan
Age
18 years and over
People
120
Run by
Fondazione Don Carlo Gnocchi ETS
See details and how to joinNCT07707245
Phase 3Taking people
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Where
Ancona, Catania, Forli', Modena, Monza, Rome, Siena, Verona
Age
18 years and over
People
698 worldwide
Run by
United Therapeutics
See details and how to joinNCT05943535 · EU 2023-504904-26-00
No phaseTaking people
Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis
Where
Modena
Age
18 years and over
People
100
Run by
University of Modena and Reggio Emilia
See details and how to joinNCT05310669
No phaseTaking people
Small Airways Disease Functional Assessment in Idiopathic Pulmonary Fibrosis (SWIFT-IPF)
Where
Milan
Age
18 years and over
People
100
Run by
University of Milan
See details and how to joinNCT07312305
No phaseTaking people
Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography
Where
Ferrara, Modena, Piacenza, Reggio Emilia
Age
18 years and over
People
500 worldwide
Run by
Azienda Unita Sanitaria Locale di Piacenza
See details and how to joinNCT07174102
No phaseTaking people
End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Undergoing Mechanical Ventilation
Where
Modena
Age
18 years to 90 years
People
40
Run by
University of Modena and Reggio Emilia
See details and how to joinNCT05098717